Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ZOTA
ZOTA | NSE
1,116.20
INR51.40
4.83%
ZOTA | NSE
Loading StockChartView...
About ZOTA
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
01/04/2026
Close
1,116.20
Open
1,114.80
High
1,136.00
Low
1,099.20
Zota Health Care Limited develops manufactures and markets pharmaceutical products in India. It offers generic drugs over-the-counter products ayurvedic products and nutraceutical products. The company provides various medicines for chronic illnesses including heart disease diabetes thyroid and others. As of March 31 2022 it operated 514 retail stores under the DAVAINDIA name in 25 states of India. Zota Health Care Limited was founded in 1995 and is headquartered in Surat India.
View LessZOTA | NSE
Risk
56.6
Sharpe
0.69
Luna's Score
51/100
Recommendation
Hold
Luna says (ZOTA | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
81.0%1 month
56.6%3 months
53.0%6 months
45.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
17.77
Debt to equity
1.06
Debt to assets
0.42
Ent. to EBITDA
305.85
Ent. to rev.
8.54
PEG
-
Other Fundamentals
EBITDA
43.95M
MarketCap
28.94B
MarketCap(USD)
310.54M
Div. yield
0.16
Op. margin
-16.49
Erngs. growth
-72.30
Rev. growth
45.70
Ret. on equity
-16.85
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
158.70
Range1M
215.70
Range3M
526.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.71
Price X volume
39.42M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 305.85 | 54.00 | Expensive |
| Ent. to Revenue | 8.54 | 7.68 | Par |
| PE Ratio | - | 53.67 | - |
| Price to Book | 17.77 | 6.76 | Expensive |
| Dividend Yield | 0.16 | 0.26 | Poor |
| Std. Deviation (3M) | 53.00 | 50.01 | Par |
| Debt to Equity | 1.06 | -0.16 | Expensive |
| Debt to Assets | 0.42 | 0.17 | Expensive |
| Market Cap | 28.94B | 129.43B | Emerging |
